Your browser doesn't support javascript.
loading
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
Brisson, Marc; Bénard, Élodie; Drolet, Mélanie; Bogaards, Johannes A; Baussano, Iacopo; Vänskä, Simopekka; Jit, Mark; Boily, Marie-Claude; Smith, Megan A; Berkhof, Johannes; Canfell, Karen; Chesson, Harrell W; Burger, Emily A; Choi, Yoon H; De Blasio, Birgitte Freiesleben; De Vlas, Sake J; Guzzetta, Giorgio; Hontelez, Jan A C; Horn, Johannes; Jepsen, Martin R; Kim, Jane J; Lazzarato, Fulvio; Matthijsse, Suzette M; Mikolajczyk, Rafael; Pavelyev, Andrew; Pillsbury, Matthew; Shafer, Leigh Anne; Tully, Stephen P; Turner, Hugo C; Usher, Cara; Walsh, Cathal.
Afiliação
  • Brisson M; Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada; Département de médecine sociale et préventive, Université Laval, Quebec City, QC, Canada; Department of Infectious Disease Epidemiology, Imperial College, London, UK. Electronic address: marc.brisson@crchudequebec.ulaval
  • Bénard É; Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada; Département de médecine sociale et préventive, Université Laval, Quebec City, QC, Canada.
  • Drolet M; Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
  • Bogaards JA; Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands.
  • Baussano I; Infection and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
  • Vänskä S; Vaccination Programme Unit, National Institute for Health and Welfare, Helsinki, Finland.
  • Jit M; Modelling and Economics Unit, Public Health England, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Boily MC; Département de médecine sociale et préventive, Université Laval, Quebec City, QC, Canada; Department of Infectious Disease Epidemiology, Imperial College, London, UK.
  • Smith MA; Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia.
  • Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands.
  • Canfell K; Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia; Lowy Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Chesson HW; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Burger EA; Center for Health Decision Science, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
  • Choi YH; National Infection Service, Public Health England, London, UK.
  • De Blasio BF; Oslo Centre for Biostatistics and Epidemiology, Division of Infectious Disease Control, Norwegian Institute of Public Health and Oslo Centre for Statistics and Epidemiology, Oslo, Norway; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • De Vlas SJ; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Guzzetta G; Fondazione Bruno Kessler, Trento, Italy.
  • Hontelez JAC; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Horn J; Epidemiological and Statistical Methods Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Jepsen MR; Section for Geography, Department of Geosciences and Natural Resource Management, University of Copenhagen, Copenhagen, Denmark.
  • Kim JJ; Center for Health Decision Science, Harvard T H Chan School of Public Health, Boston, MA, USA.
  • Lazzarato F; Infection and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France; Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Matthijsse SM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Mikolajczyk R; Epidemiological and Statistical Methods Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Pavelyev A; Merck Research Laboratories, Rahway, NJ, USA.
  • Pillsbury M; Merck Research Laboratories, Rahway, NJ, USA.
  • Shafer LA; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
  • Tully SP; Infection and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
  • Turner HC; Department of Infectious Disease Epidemiology, Imperial College, London, UK.
  • Usher C; National Centre for Pharmacoeconomics (NCPE Ireland), Dublin, Ireland.
  • Walsh C; Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland.
Lancet Public Health ; 1(1): e8-e17, 2016 11.
Article em En | MEDLINE | ID: mdl-29253379
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Imunidade Coletiva / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Lancet Public Health Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Imunidade Coletiva / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Lancet Public Health Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido